Small-diameter nerve fiber neuropathy in systemic lupus erythematosus

Archives of Neurology

Volumn 63, Issue 3, 2006, Pages 401-404

  Gøransson, Lasse G ^a,b   Tjensvoll, Anne B ^a   Herigstad, Anita ^a   Mellgren, Svein I ^c,d   Omdal, Roald ^a,b  

^a STAVANGER UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

^c UNIVERSITY OF TROMSØ   (Norway)

^d UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NERVE CONDUCTION; NERVE FIBER; NEUROLOGIC EXAMINATION; NEUROPATHY; NORWAY; OUTCOMES RESEARCH; POLYNEUROPATHY; PRIORITY JOURNAL; SKIN BIOPSY; SYSTEMIC LUPUS ERYTHEMATOSUS; UNIVERSITY HOSPITAL;

ADULT; AGED; BIOPSY; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; NERVE FIBERS; NEURAL CONDUCTION; PERIPHERAL NERVOUS SYSTEM DISEASES; RETROSPECTIVE STUDIES; SKIN;

EID: 33644904619     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneur.63.3.401     Document Type: Article

References (26)

1. Estes D, Christian C. The natural history of systemic lupus erythematosus by prospective analysis. Medicine (Baltimore). 1971;50:85-95.
2. Omdal R, Henriksen OA, Mellgren SI, Husby G. Peripheral neuropathy in systemic lupus erythematosus. Neurology. 1991;41:808-811.
3. Sivri A, Hascelik Z, Celiker R, Basgöze O. Early detection of neurological involvement in systemic lupus erythematosus patients. Electromyogr Clin Neurophysiol. 1995;35:195-199.
4. Huynh C, Ho SL, Fong KY, Cheung RTF, Mok CC, Lau CS. Peripheral neuropathy in systemic lupus erythematosus. J Clin Neurophysiol. 1999;16:164-168.
5. Omdal R, Løseth S, Torbergsen T, Koldingsnes W, Husby G, Mellgren SI. Peripheral neuropathy in systemic lupus erythematosus: a longitudinal study. Acta Neurol Scand. 2001;103:386-391.
6. Omdal R, Mellgren SI, Husby G, Salvesen R, Henriksen OA, Torbergsen T. A controlled study of peripheral neuropathy in systemic lupus erythematosus. Acta Neurol Scand. 1993;88:41-46.
7. Omdal R, Bekkelund SI, Mellgren SI, Husby G. C-fibre function in systemic lupus erythematosus. Lupus. 1996;5:613-617.
8. Kennedy WR, Wendelschafer-Crabb G. The innervation of human epidermis. J Neurol Sci. 1993;115:184-190.
9. McArthur JC, Stocks EA, Hauer P, Cornblath DR, Griffin JW. Epidermal nerve fiber density: normative reference range and diagnostic efficiency. Arch Neurol. 1998;55:1513-1520.
10. Gøransson LG, Mellgren SI, Lindal S, Omdal R. The effect of age and gender on epidermal nerve fiber density. Neurology. 2004;62:774-777.
11. Omdal R, Mellgren SI, Gøransson L, et al. Small nerve fiber involvement in systemic lupus erythematosus: a controlled study. Arthritis Rheum. 2002;46:1228-1232.
12. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40:1725.
13. Dyck PJ, Bushek W, Spring EM, et al. Vibratory and cooling detection thresholds compared with other tests in diagnosing and staging diabetic neuropathy. Diabetes Care. 1987;10:432-440.
14. Dyck PJ, Davies JL, Litchy WJ, O'Brien PC. Longitudinal assessment of diabetic polyneuropathy using a composite score in the Rochester Diabetic Neuropathy Study cohort. Neurology. 1997;49:229-239.
15. Apfel SC, Asbury AK, Bril V, et al; Ad Hoc Panel on Endpoints for Diabetic Neuropathy Trials. Positive neuropathic sensory symptoms as endpoints in diabetic neruopathy trials. J Neurol Sci. 2001;189:3-5.
16. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH; Committee on Prognosis Studies in SLE. Derivation of the SLEDAI: a disease activity index for lupus patients. Arthritis Rheum. 1992;35:630-640.
17. Omdal R, Waterloo K, Koldingsnes W, Husby G, Mellgren SI. Somatic and psychological features of headache in systemic lupus erythematosus. J Rheumatol. 2001;28:772-779.
18. Lacomis D. Small-fiber neuropathy. Muscle Nerve. 2002;26:173-188.
19. Sumner CJ, Sheth S, Griffin JW, Cornblath DR, Polydefkis M. The spectrum of neuropathy in diabetes and impaired glucose tolerance. Neurology. 2003;60:108-111.
20. Dabby R, Weimer LH, Hays AP, Olarte M, Latov N. Antisulfatide antibodies in neuropathy: clinical and electrophysiologic correlates. Neurology. 2000;54:1448-1452.
21. Pestronk A, Choksi R, Logigian E, Al-Lozi MT. Sensory neuropathy with monoclonal IgM binding to a trisulfated heparin disaccharide. Muscle Nerve. 2003;27:188-195.
22. Belmont HM, Abramson SB, Lie JT. Pathology and pathogenesis of vascular injury in systemic lupus erythematosus: interactions of inflammatory cells and activated endothelium. Arthritis Rheum. 1996;39:9-22.
23. Johnson AE, Cavalcanti FS, Gordon C, et al. Cross-sectional analysis of the differences between patients with systemic lupus erythematosus in England, Brazil and Sweden. Lupus. 1994;3:501-506.
24. Ståhl-Hallengren C, Jönsen A, Nived O, Sturfelt G. Incidence studies of systemic lupus erythematosus in southern Sweden: increasing age, decreasing frequency of renal manifestations and good prognosis. J Rheumatol. 2000;27:685-691.
25. Gilboe IM, Kvien TK, Husby G. Disease course in systemic lupus erythematosus: changes in health status, disease activity, and organ damage after 2 years. J Rheumatol. 2001;28:266-274.
26. Stein M, Bell MJ, Ang LC. Hydroxychloroquine neuromyotoxicity. J Rheumatol. 2000;27:2927-2931.